A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans

Diabetologia. 2011 May;54(5):1066-74. doi: 10.1007/s00125-011-2071-2. Epub 2011 Feb 18.

Abstract

Aims/hypothesis: We sought to establish if stem cells contained in cord blood cell allografts have the capacity to differentiate into insulin-expressing beta cells in humans.

Methods: We studied pancreases obtained at autopsy from individuals (n = 11) who had prior opposite-sex cord blood transplants to reconstitute haematopoiesis. Pancreatic tissue sections were stained first by XY-fluorescence in situ hybridisation and then insulin immunohistochemistry. Pancreases obtained at autopsy from participants without cord blood cell infusions served as controls (n = 11).

Results: In the men with prior transplant of female cord blood, there were 3.4 ± 0.3% XX-positive insulin-expressing islet cells compared with 0.32 ± 0.05% (p < 0.01) in male controls. In women with prior transplant of male cord blood cells we detected 1.03 ± 0.20% XY insulin-expressing islet cells compared with 0.03 ± 0.03 in female controls (p < 0. 001).

Conclusions/interpretation: Cord blood stem cells have the capacity to differentiate into insulin-expressing cells in non-diabetic humans. It remains to be established whether these cells have the properties of beta cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cell Differentiation / physiology
  • Child
  • Child, Preschool
  • Female
  • Fetal Blood / cytology*
  • Humans
  • Infant
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / metabolism*
  • Male
  • Middle Aged
  • Stem Cell Transplantation
  • Stem Cells / cytology*
  • Stem Cells / metabolism*
  • Transplantation, Homologous
  • Young Adult